Crawford faces obstacles in nomination process

Lester Crawford's nomination to head the FDA won committee approval on Wednesday but is still facing some major hurdles before reaching a full Senate vote.
Although the Senate committee on Health, Education, Labor and Pensions approved the nomination, Sens. Patty Murray, D-Wash., and Hillary Clinton, D-N.Y., have placed a hold on Crawford's nomination, blocking immediate consideration of it.
The hold will remain in place until the FDA issues a yes or no decision on allowing OTC sales of Barr Pharmaceuticals' emergency contraceptive Plan B. In January, an FDA advisory panel recommended 24-3 in favor of OTC status for the drug but at press time the agency had yet to make a final determination on the matter.
You must be a registered member of MMM to post a comment.

Email Newsletters


As US pharma continued its quest for a Grand Prix at the Lions Health international festival of creativity, MM&M went on location to Cannes, France. Missed our coverage from June? Now, we're giving you an opportunity to catch up on some of what you missed. Download our e-book on the two-day festival, recapping the event, rounding up the best of the speakers, offering perspective and listing all of the winners. Click here to download.


The most recent MM&M Skill Sets Live event surveyed a range of issues relating to one of the hottest promotional spaces in healthcare. Speakers and panelists at the morning-long session, including promotional- and multichannel-minded executives from GSK, Epocrates, Treato and Montefiore Medical Center, weighed in on topics designed to help marketers demystify the challenges associated with non-personal promotion. Click here.